Showing results (91-100 of 559) with videos related to

Sort By:
Pageof 56
Circulation|March 16, 2006
Lipoprotein-associated phospholipase A2 and its association with cardiovascular outcomes in patients with acute coronary syndromes in the PROVE IT-TIMI 22 (PRavastatin Or atorVastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction) trialMichelle O'Donoghue, David A Morrow, Marc S Sabatine, et al.
Diabetes Care|April 2, 2010
Effect of ranolazine on A1C and glucose levels in hyperglycemic patients with non-ST elevation acute coronary syndromeJeffrey W Chisholm, Allison B Goldfine, Arvinder K Dhalla, et al.
European Heart Journal|December 8, 2025
Non-ST-segment elevation acute coronary syndrome: understanding the full spectrum to guide managementStefano Savonitto, Joseph S Alpert, Holger Thiele, et al.
American Heart Journal|March 3, 2009
Baseline hemoglobin concentration and creatinine clearance composite laboratory index improves risk stratification in ST-elevation myocardial infarctionRoberto R Giraldez, Marc S Sabatine, David A Morrow, et al.
Lancet (London, England)|March 3, 2009
Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trialGilles Montalescot, Stephen D Wiviott, Eugene Braunwald, et al.
European Heart Journal|September 29, 2004
Severity of heart failure, treatments, and outcomes after fibrinolysis in patients with ST-elevation myocardial infarctionAmir Kashani, Robert P Giugliano, Elliott M Antman, et al.
The American Journal of Cardiology|June 21, 2006
Association of platelet counts on presentation and clinical outcomes in ST-elevation myocardial infarction (from the TIMI Trials)Hung Q Ly, Ajay J Kirtane, Sabina A Murphy, et al.
Circulation. Cardiovascular Quality and Outcomes|December 25, 2009
Economic impact of angina after an acute coronary syndrome: insights from the MERLIN-TIMI 36 trialSuzanne V Arnold, David A Morrow, Yang Lei, et al.
The American Journal of Medicine|November 3, 2007
TIMI risk index and the benefit of enoxaparin in patients with ST-elevation myocardial infarctionChristian T Ruff, Stephen D Wiviott, David A Morrow, et al.
American Heart Journal|July 10, 2003
Angiographic and clinical characteristics associated with the development of Q-wave and non-Q-wave myocardial infarction in the thrombolysis in myocardial infarction (TIMI) 14 trialSabina A Murphy, Kent Dauterman, James A de Lemos, et al.
Pageof 56